Sonodynamic Therapy Phase 1/2 Clinical Trial For Recurrent Glioblastoma
You may be eligible if:
- You are 18 years or older.
- You have a histologically diagnosed primary glioblastoma that has recurred or progressed, and resection is not indicated.
- You received previous first-line treatment with standard-of-care radiotherapy and temozolomide. Temozolomide is only required if the tumor has at least partial methylation of the MGMT promoter.